Loading...
Prone position improves Oxygenation in COVID-19 Patients

What is Proning?

A person is put in a prone position to avoid being put on a ventilator. Proning refers to a position in which an individual lies down flat on the belly and the chest. The most significant advantage of this therapy is that very little or no equipment is needed. It is an effective treatment method for ARDS (Acute Respiratory Distress Syndrome).

The satisfying mechanism of Proning proves the efficacy of this therapy.

When an individual flips on his stomach, the blood eventually gets more oxygen as ox...

COVID-19, severe acute respiratory syndrome coronavirus 2, sars-cov-2, prone position, respiratory distress syndrome, adult, pandemics
READ MORE
Covid 19 Third-wave and Cancer Patients: What’s the connection?

After the measureless loss to millions of people in the first two waves, now the mention of the forthcoming third wave is nothing more than a curse to human life. 

Covid has largely infected the older age group in the last year but in the second wave, the adults and children also got infected due to the mutant variant. Although problems can occur in any case, patients with the immune-compromised state are more likely to get infected as compared to others. 

Cancer is a known immunocompromised condition and it is a known risk factor. Furthermore, cancer has become one of the...

covid, coronavirus, covid-19, covid third wave, corona effect on cancer patients
READ MORE
Molnupiravir: A potential COVID-19 drug

Facts You Must Know

Salt composition: Molnupiravir

Dosage form: Capsules

Packaging: Strip

Administration route: Oral

Prescription required: Yes

Storage: Store at room temperature.

Shelf life: 18 months

Common brand names: Monuvir and Lagevrio

Indication:  Adult patients with COVID-19 who are at risk of developing severe symptoms

Recommended dose: 800mg dose every 12 hours for 5 days

Pediatric Patients: Not recommended for use in patients aged below 19 years

What is Molnupiravir?

...

molnupiravir | covid-19 | Pharmaceuticals | SKF Pharmaceuticals | Lagevrio
READ MORE
Pfizer’s Paxlovid First Oral Antiviral for Covid-19

Paxlovid (Nirmatrelvir/Ritonavir) is an investigational SARS-CoV-2 protease inhibitor antiviral therapy that received an emergency use authorization (EUA) by the Food and Drug Administration (FDA). The agency confirmed that Paxlovid is authorized for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients who are at an increased risk of progressing to severe illness. The dosage recommended for this drug is three pills (one of ritonavir and two of nirmatrelvir) twice a day for a total of 30 pills.

They added that ...

paxlovid, antiviral, covid-19, nirmatrelvir, ritonavir
READ MORE